Market Research Reports

High Potency Active Pharmaceutical Ingredients (HPAPIs) Market - Global Industry Analysis, Size, Growth, Share And Forecast 2012 - 2018

110pages
Published Date: 2012-11-25
 

Description


DESCRIPTION

In this research report Transparency Market Research analyzes the global high-potency active pharmaceutical ingredients market (HPAPI) along with market dynamics and present market condition. It also covers the market of high-potency active pharmaceutical ingredients types and application in different regions of the world namely, North America, Europe, Asia and RoW along with their sub segments. Moreover, the report provides detailed and in-depth analysis of the HPAPI market, with their estimated figures and forecast from 2012 to 2018, along with compound annual growth rate from 2012 to 2018.

The global high-potency active pharmaceutical ingredients market has shown favorable growth trend in the last few years and is expected to grow rapidly in the forecasted period. The demand of oncology products is further expected to drive the growth of this market. The high level of competition in this market is due to new entrants fragmenting the market. HPAPI market by type of synthesis has been covered in this report providing their estimates and forecast from 2012 to 2018. The drivers, restraints and opportunities have also been covered broadly in this report along with their impact analysis. These market dynamics will be highly helpful in taking corporate decisions related to the HPAPI market.

We have used secondary research for deriving our market numbers for each segment of the research report and further validated our analysis with C-level executives of major companies operating in the high-potency active pharmaceutical ingredients market through means of primary research to finally come up with our results. This report also provides company profiles of the major players in the HPAPI market. Our company profile provides company and financial overview, business, strategies adopted by the companies, SWOT analysis and their recent developments which can help in assessing the competition in the market. Some of the major companies included in this report are Pfizer, Roche, Novartis, GlaxoSmithKline Pharmaceuticals Ltd., BASF Se, Hospira Inc., Matrix Laboratories Limited, Covidein Plc and Astra Geneca International, among others.

In this research report Transparency Market Research analyzes the performance of high potency active pharmaceutical ingredients market in a global scenario. The research provides in-depth analysis of market sales, trend analysis by segments and demand by geography. The report covers all the major product types and application segments of the HPAPIs market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global high potency active pharmaceutical ingredients market as below:
HPAPI Market, 2012 – 2018
  • Introduction   
  • HPAPI Classification as per Safebridge Consultants   
  • Overview: HPAPI Global Market  
  • Manufacturing Capabilities   
  • Handling requirements   
  • Personnel considerations   
  • Plant & equipment   
  • Technology

HPAPI Market, By Type of Synthesis, 2012 – 2018

Overview   

Sub-Segments Of HPAPI Market 

By Type Of Synthesis   
  • Synthetic HPAPI
  • Biotech HPAPI
By Type of Manufacturers   
  • Captive or In-house manufacturers
  • Merchant or Third party manufacturers
By Type of Market  
  • Innovative   
  • Generic

In addition the report provides a cross-sectional analysis of all the above segments with respect to the following geographical markets:
  • North America
  • Europe
  • Asia
  • RoW

The in-depth research and high level analysis will allow high potency active pharmaceutical ingredients product manufacturers, lawmakers, large retailers, medical companies and research and development agencies to make informed decisions about high potency active pharmaceutical Ingredients product manufacturing, designing marketing, growth strategies and gaining competitive advantage.

Table of Contents


TABLE OF CONTENT

1. Preface
    1.1. Report Description
    1.2. Research Methodology

2. Executive Summary

3. HPAPI Market Overview
    3.1. Introduction
    3.2. HPAPI Market Size Estimate and Forecast, 2012 - 2018
    3.3. Technology Trends   
           3.3.1. Continuous Processing Technology   
           3.3.2. Separation Technology   
                     3.3.2.1. Fermentation process   
                     3.3.2.2. Purification process   
                     3.3.2.3. Filtration process   
                     3.3.2.4. Drying process   
    3.4. Micro Reactor Technology   
    3.5. Benefits From Micro Reactor Technology & Flow Chemistry   
    3.6. Green Chemistry Manufacturing
    3.7. Market Dynamics   
           3.7.1. Drivers   
           3.7.2. Restraints   
           3.7.3. Opportunities           
    3.8. Key Market Strategies for Success
           3.8.1. Embarking on advanced technology   
           3.8.2. Joint ventures of API manufacturers   
           3.8.3. Approvals of DMFs   
           3.8.4. Tracking of the off-patents   
    3.9. Key Issues in the Market   
           3.9.1. Lack of quality standards   
           3.9.2. Regulatory affairs   
           3.9.3. IP Protection to the Asian market   
           3.9.4. Product differentiation a major concern of API manufacturers
    3.10. Five Force Analysis
           3.10.1. Bargaining Power of Suppliers
           3.10.2. Threat of Substitutes
           3.10.3. Bargaining Power of Buyers
           3.10.4. Threat of New Entrants
           3.10.5. Competitive Rivalry within the Industry

4. HPAPI Market, 2012 – 2018
    4.1. Introduction   
    4.2. HPAPI Classification As Per Safebridge Consultants   
    4.3. Overview: HPAPI Global Market   
    4.4. Manufacturing Capabilities   
           4.4.1. Handling requirements   
           4.4.2. Personnel considerations   
           4.4.3. Plant & equipment   
           4.4.4. Technology

5. HPAPI Market, By Type of Synthesis, 2012 – 2018
    5.1. Overview   
    5.2. Sub-Segments Of HPAPI Market
    5.3. By Type Of Synthesis   
           5.3.1. Synthetic HPAPI  
           5.3.2. Biotech HPAPI 
    5.4. By Type of Manufacturers   
           5.4.1. Captive or In-house manufacturers
           5.4.2. Merchant or Third party manufacturers
    5.5. By Type of Market  
           5.5.1. Innovative HPAPI
           5.5.2. Generic HPAPI

6. HPAPI Market by Geography
    6.1. North America
    6.2. Europe
    6.3. Asia Pacific
    6.4. RoW

7. Competitive Landscape
    7.1. Summary
    7.2. Market Share by Key Players
    7.3. Competitive Strategy by Key Players
    7.4. Agreements and collaborations
    7.5. Recent Developments

8. Recommendations
    8.1. Market Strategy for Success
    8.2. Barriers to be Considered
    8.3. Future Assumptions

9. Company Profiles
    9.1. Boehringer Ingelheim Gmbh
    9.2. Covidien Plc
    9.3. BASF Se
    9.4. Hospira Inc
    9.5. Matrix Laboratories Limited
    9.6. Novartis International Ag
    9.7. Pfizer Centresource
    9.8. Ranbaxy Laboratories Limited
    9.9. Royal Dsm Nv
    9.10. Teva Pharmaceutical Industries Limited   
    9.11. Others

Enquiry Before Buying


 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research